MATTER 360 Doubles Impact, Repurposing 3.3 Million Pounds of Medical Surplus in 2021

MATTER (Minnesota-based global ) today announced, through the MATTER 360 initiative of repurposing medical equipment and supplies, that 3.3 million pounds of medical surplus was saved from landfills in 2021, an increase from 1.5 million pounds in 2020.

MATTER has been involved in repurposing medical equipment and supplies since 2002, and in the last three years alone, repurposed more than 5 million pounds.

MATTER repurposes medical equipment and supplies to aid people and reduce landfill non-hazardous medical waste, accomplishing this through distributions to international hospital and clinic partners, from resale efforts, and by recycling.

Established partnerships with hospitals and clinics provide MATTER the opportunity to repurpose medical supplies and equipment, which accounts for 90 percent of donations. As a result, medical equipment and supplies that are no longer useful in the United States, take on a renewed purpose around the globe.

Lisa Campbell, Director of Purchased Services Contracting at UnityPoint Health commented, “The most important thing is that we want to make a difference in people’s lives all over the world. We have this reach in Iowa, Illinois, and Wisconsin, but we want to touch more lives than that. This is such important work, being able to help organizations like MATTER with things that would otherwise go into the landfill, or we’d have to pay for someone to haul them away. It makes perfect sense to partner with you. It’s a wonderful relationship, our whole vision and purpose are to show people how much they matter, and what better way to do that than by partnering with MATTER.”

Of the remaining supplies and equipment received, MATTER remarkets approximately 4 percent via sales channels to support MATTER projects and operations. Unusable supplies and equipment, approximately 5 percent, is recycled annually, resulting in total waste of just 1%.

“We remain committed to helping our ever-growing number of partners, easily and efficiently, donate medical supplies and equipment to benefit others when no longer useful in their present location,” stated Joel Anderson, Executive VP of MATTER 360. “We greatly appreciate the trust that our partners, including hospital and clinics around the United States, place in us.”

SourceMATTER

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.